Close

Avacta’s Rapid Antigen Test Is Confirmed to Detect SARS-CoV-2 New Variants

Go back to Avacta’s Rapid Antigen Test Is Confirmed to Detect SARS-CoV-2 New Variants
AVOCENT (NASDAQ: AVCT) Delayed: 0.60 --0 (-0%)
Previous Close $0.60    52 Week High $25.13 
Open $0.60    52 Week Low $9.89 
Day High $0.60    P/E N/A 
Day Low $0.60    EPS $-1.04 
Volume 8,416